PD1 and PARP for Maintenance Therapy in NSLLC
Clinical trial NCT05392686 · UNKNOWN
Trial details
- NCT number
- NCT05392686
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-20
- Primary completion
- 2022-06-21
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.